Levonadifloxacin (Emrok O) 500 mg
Emrok O (Levonadifloxacin) 500 mg, 4 tablets is a next-generation fluoroquinolone antibiotic designed for the treatment of complex and resistant bacterial infections.

The active ingredient, levonadifloxacin, provides broad-spectrum antibacterial activity, including effectiveness against Gram-positive pathogens such as MRSA, as well as selected Gram-negative bacteria.

Key Features

• Brand Name: Emrok O
• Active Ingredient: Levonadifloxacin
• Strength: 500 mg
• Form: tablets
• Pack Size: 4 tablets (2×2)
• Class: fluoroquinolone antibiotic

Mechanism of Action

Levonadifloxacin inhibits bacterial DNA gyrase and topoisomerase IV, disrupting DNA replication and leading to bacterial cell death.

The medication provides:

• activity against resistant pathogens
• rapid infection control
• good tissue penetration
• targeted antibacterial action

Indications

Used for:

• skin and soft tissue infections
• complicated bacterial infections
• infections caused by resistant organisms
• other infections as prescribed

Benefits

• effective against MRSA
• advanced fluoroquinolone
• suitable for difficult-to-treat infections
• convenient short-course packaging

Administration

For oral use. Dosage and duration should be determined by a healthcare professional.

Important Notice

Prescription-only antibiotic. Do not self-medicate or discontinue treatment early.

FAQ

What is Levonadifloxacin?

Levonadifloxacin is a next-generation fluoroquinolone antibiotic used to treat bacterial infections.

What is Emrok O used for?
It is used for skin infections, complicated bacterial infections, and infections caused by resistant bacteria.

How does it work?
It blocks bacterial enzymes required for DNA replication, leading to bacterial death.

What makes it different from other antibiotics?
It is effective against MRSA and other resistant pathogens.

How should it be taken?
It is taken orally as prescribed by a healthcare professional.

Ask a question or inquire about delivery to your country

Telegram

WhatsApp